Trials / Completed
CompletedNCT00600769
Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)
Open Study of Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 210 (actual)
- Sponsor
- The University of Texas Health Science Center at Tyler · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Use of oral clarithromycin for treatment of chronic lung disease due to Mycobacterium avium-intracellulare and other non-tuberculous Mycobacteria
Detailed description
Oral clarithromycin for treatment of MAC and other nontuberculous mycobacteria in adults with clinical history
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clarithromycin | Dosage dependent on clinical factors such as age, weight and patient-specific health status |
Timeline
- Start date
- 1991-01-01
- Primary completion
- 2006-11-01
- Completion
- 2017-05-18
- First posted
- 2008-01-25
- Last updated
- 2017-05-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00600769. Inclusion in this directory is not an endorsement.